Document is current
Any future updates will be listed below
-
Authors
Lamantia, Valérie
Bissonnette, Simon
Beaudry, Myriam
Cyr, Yannick
Rosiers, Christine Des
Baass, Alexis
Faraj, May
-
Funding
Funding for this research was provided by:
Canadian Institute of Health Research (#123409)
- License Information
-
More Information
Article History
Received: 29 January 2024
Accepted: 19 September 2024
First Online: 7 November 2024
Declarations
:
: The omega-3 supplementation used in this trial (Webber Naturals Triple Strength Omega-3) was provided as a donation for academic research by Factors Group of Nutritional Companies that ditribute this brand of omega-3 in Canada. Factors Group for academic research and Webber Naturals have no role in the conceptualization, design, data collection, analysis, decision to publish, or preparation of the manuscript in any form. This is an investigator originated study that was funded by Canadian Institutes for Health Research. The authors do not have any competing interests.
: Subjects signed an informed consent form approved by the IRCM Human Ethics Board prior to participation in the study, which was conducted in accordance with the Declaration of Helsinki.
